J Korean Hip Soc.  2010 Dec;22(4):323-326. 10.5371/jkhs.2010.22.4.323.

Hip Joint Surgery without Transfusion in Patients Who Were Jehovah's Witnesses: A Report of Two Cases

• Yoon TR
• Park KS
• Park CH
• Park HW

• KMID: 1461189
• DOI: http://doi.org/10.5371/jkhs.2010.22.4.323

Abstract

Jehovah's Witnesses are widely known for their prohibition for accepting blood transfusion. Because of the firm refusal to receive transfused blood and blood components by Jehovah's Witnesses, the management of Jehovah's Witness patients with severe bleeding is often complicated by medical, ethical and legal concerns. We report here on two cases of successful treatment of Jehovah's Witnesses who underwent total hip replacement for secondary osteoarthritis and Chiari osteotomy for acetabular dysplasia.

Keyword

Hip joint surgery; Bloodless operation; Jehovah's Witnesses

MeSH Terms

Arthroplasty, Replacement, Hip
Blood Transfusion
Disulfiram
Hemorrhage
Hip
Hip Joint
Humans
Jehovah's Witnesses
Osteoarthritis
Osteotomy
Wit and Humor as Topic
Disulfiram

Reference

1. Copley LA, Richards BS, Safavi FZ, Newton PO. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine. 1999. 24:219–222.

2. Dixon JL, Smalley MG. Jehovah's Witnesses. The surgical/ethical challenge. JAMA. 1981. 246:2471–2472.

3. DiPasquale T, Greiwe RM, Simmons P, et al. Temporary partial intra-iliac balloon occlusion for the treatment of acetabulum fracture in a Jehovah's Witness: a case report. J Orthop Trauma. 2005. 19:415–419.

4. Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg. 2010. 18:132–138.

5. Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008. 358:784–793.

6. Ball AM, Winstead PS. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. Pharmacotherapy. 2008. 28:1383–1390.

7. Kawahara Y, Kitamura M, Kunishima Y. Hemodilutional autologous blood transfusion and the roles of medical technologists as specialists of the blood transfusion. Rinsho Byori. 2009. 57:113–117.

8. Nash MJ, Cohen H. Management of Jehovah's Witness patients with haematological problems. Blood Rev. 2004. 18:211–217.